Stock ORTI B ORTIVUS AB
Add to a list
To use this feature you must be a member
Log inSign up

Financials Ortivus AB

Equities

ORTI B

SE0000123085

Advanced Medical Equipment & Technology

Market Closed - Nasdaq Stockholm
Other stock markets
 06:34:19 2024-04-26 am EDT 		5-day change 1st Jan Change
2.57 SEK -1.15% Intraday chart for Ortivus AB -4.46% -30.73%
Apr. 15 Ortivus CFO to Step Down in July MT
Apr. 15 Ortivus AB Announces Resignation of Viveka Hiort Af Ornäs as Chief Financial Officer, Effective from July 12, 2024 CI

Valuation

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Capitalization 1 52.32 167 227.9 232.1 246.2 166.1
Enterprise Value (EV) 1 61.98 161.5 206.8 213.3 244.7 170.3
P/E ratio -3.67 x -9.14 x 20.1 x 25.2 x 41.5 x -9.01 x
Yield - - - - - -
Capitalization / Revenue 1 x 3.28 x 2.12 x 2.46 x 2.36 x 1.98 x
EV / Revenue 1.19 x 3.18 x 1.92 x 2.26 x 2.34 x 2.03 x
EV / EBITDA -7.15 x -14.9 x 27.6 x 16 x 32.3 x -11.1 x
EV / FCF 16.4 x 81.7 x 22.4 x -19.5 x -21.5 x 40.5 x
FCF Yield 6.09% 1.22% 4.46% -5.12% -4.64% 2.47%
Price to Book 22.6 x 19 x 11.6 x 7.89 x 6.9 x 9.5 x
Nbr of stocks (in thousands) 31,145 44,307 44,307 44,307 44,307 44,307
Reference price 2 1.580 3.760 5.150 5.240 5.520 3.710
Announcement Date 3/20/19 3/13/20 4/13/21 4/3/22 3/31/23 3/28/24
1SEK in Million2SEK
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net sales 1 52.2 50.85 107.6 94.27 104.5 84.08
EBITDA 1 -8.67 -10.87 7.498 13.34 7.571 -15.34
EBIT 1 -12.87 -15.06 6.922 12.57 6.66 -16.4
Operating Margin -24.66% -29.61% 6.43% 13.33% 6.37% -19.5%
Earnings before Tax (EBT) 1 -13.39 -16.01 11.33 9.211 5.813 -18.19
Net income 1 -13.39 -16.01 11.33 9.211 5.892 -18.24
Net margin -25.65% -31.48% 10.53% 9.77% 5.64% -21.7%
EPS 2 -0.4300 -0.4115 0.2558 0.2079 0.1330 -0.4118
Free Cash Flow 1 3.777 1.978 9.217 -10.92 -11.37 4.205
FCF margin 7.24% 3.89% 8.57% -11.58% -10.88% 5%
FCF Conversion (EBITDA) - - 122.92% - - -
FCF Conversion (Net income) - - 81.33% - - -
Dividend per Share - - - - - -
Announcement Date 3/20/19 3/13/20 4/13/21 4/3/22 3/31/23 3/28/24
1SEK in Million2SEK
Estimates

Balance Sheet Analysis

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net Debt 1 9.67 - - - - 4.19
Net Cash position 1 - 5.5 21.1 18.8 1.46 -
Leverage (Debt/EBITDA) -1.115 x - - - - -0.2733 x
Free Cash Flow 1 3.78 1.98 9.22 -10.9 -11.4 4.21
ROE (net income / shareholders' equity) -151% -293% 79.7% 37.5% 18.2% -69.2%
ROA (Net income/ Total Assets) -25.9% -30% 8.53% 11.3% 5.13% -12.6%
Assets 1 51.8 53.27 132.9 81.48 114.8 144.6
Book Value Per Share 2 0.0700 0.2000 0.4400 0.6600 0.8000 0.3900
Cash Flow per Share 2 0.1100 0.2000 0.5000 0.5000 0.1700 0.0300
Capex 1 0.28 0.33 1.78 0.9 1.09 0.42
Capex / Sales 0.54% 0.65% 1.66% 0.95% 1.04% 0.5%
Announcement Date 3/20/19 3/13/20 4/13/21 4/3/22 3/31/23 3/28/24
1SEK in Million2SEK
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sector Other Advanced Medical Equipment & Technology

1st Jan change Capi.
ORTIVUS AB Stock Ortivus AB
-30.73% 10.69M
THERMO FISHER SCIENTIFIC Stock Thermo Fisher Scientific
+8.07% 219B
DANAHER CORPORATION Stock Danaher Corporation
+6.59% 183B
INTUITIVE SURGICAL, INC. Stock Intuitive Surgical, Inc.
+11.26% 133B
BOSTON SCIENTIFIC CORPORATION Stock Boston Scientific Corporation
+26.57% 108B
SIEMENS HEALTHINEERS AG Stock Siemens Healthineers AG
+0.65% 63.06B
EDWARDS LIFESCIENCES CORPORATION Stock Edwards Lifesciences Corporation
+13.35% 52.02B
SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD. Stock Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
-0.62% 48.2B
AGILENT TECHNOLOGIES, INC. Stock Agilent Technologies, Inc.
-0.93% 40.37B
GE HEALTHCARE TECHNOLOGIES INC. Stock GE HealthCare Technologies Inc.
+11.54% 39.35B
Other Advanced Medical Equipment & Technology
  1. Stock Market
  2. Equities
  3. ORTI B Stock
  4. Financials Ortivus AB